OPEN EDUCATIONAL RESOURCES

UPA PERPUSTAKAAN UNEJ | NPP. 3509212D1000001

  • Home
  • Admin
  • Select Language :
    Arabic Bengali Brazilian Portuguese English Espanol German Indonesian Japanese Malay Persian Russian Thai Turkish Urdu

Search by :

ALL Author Subject ISBN/ISSN Advanced Search

Last search:

{{tmpObj[k].text}}
Image of Optimization of Pharmaceutical R&D Programs and Portfolios
Design and Investment Strategy
Bookmark Share

Text

Optimization of Pharmaceutical R&D Programs and Portfolios Design and Investment Strategy

ANTONIJEVIC, Zoran - Personal Name;

Very little has been published on optimization of pharmaceutical portfolios. Moreover, most of published literature is coming from the commercial side, where probability of technical success (PoS) is treated as fixed, and not as a consequence of development strategy or design. In this book there is a strong focus on impact of study design on PoS and ultimately on the value of portfolio. Design options that are discussed in different chapters are dose-selection strategies, adaptive design and enrichment. Some development strategies that are discussed are indication sequencing, optimal number of programs and optimal decision criteria.

This book includes chapters written by authors with very broad backgrounds including financial, clinical, statistical, decision sciences, commercial and regulatory. Many authors have long held executive positions and have been involved with decision making at a product or at a portfolio level. As such, it is expected that this book will attract a very broad audience, including decision makers in pharmaceutical R&D, commercial and financial departments. The intended audience also includes portfolio planners and managers, statisticians, decision scientists and clinicians.

Early chapters describe approaches to portfolio optimization from big Pharma and Venture Capital standpoints. They have stronger focus on finances and processes. Later chapters present selected statistical and decision analysis methods for optimizing drug development programs and portfolios. Some methodological chapters are technical; however, with a few exceptions they require a relatively basic knowledge of statistics by a reader.


Availability

No copy data

Detail Information
Series Title
-
Call Number
-
Publisher
: Springer Cham., 2015
Collation
-
Language
English
ISBN/ISSN
978-3-319-09075-7
Classification
NONE
Content Type
text
Media Type
computer
Carrier Type
online resource
Edition
-
Subject(s)
Optimization
Operations Research and Decision Theory
Biostatistics
Specific Detail Info
-
Statement of Responsibility
Zoran Antonijevic
Other Information
Cataloger
Yudi
Source
-
Validator
-
Other version/related

No other version available

File Attachment
  • Optimization of Pharmaceutical R&D Programs and Portfolios Design and Investment Strategy
Comments

You must be logged in to post a comment

OPEN EDUCATIONAL RESOURCES

Search

start it by typing one or more keywords for title, author or subject


Select the topic you are interested in
  • Computer Science, Information & General Works
  • Philosophy & Psychology
  • Religion
  • Social Sciences
  • Language
  • Pure Science
  • Applied Sciences
  • Art & Recreation
  • Literature
  • History & Geography
Icons made by Freepik from www.flaticon.com
Advanced Search
Where do you want to share?